Sponsors and CROs no longer hire clinical research associates (CRAs) the way they did a decade ago. Trials have spread out of any single home country, monitoring has shifted partly remote, and the buyer's question is now structurally different: not "who is the best CRA in our city," but "where does the right CRA live, and how do we employ them legally without standing up an entity for one hire."
This guide is the operating answer. It maps where CRAs actually live in 2026, what they cost loaded, how to choose between contractor, Employer of Record (EOR), and local entity, and what a clean 30/60/90-day rollout looks like. It is the role-level companion to our hub on why medical companies use EOR.
Why CRA hiring has shifted out of one-country models
Three forces broke the single-country CRA model.
Trial geography moved. ClinicalTrials.gov registrations span 220+ countries, and sponsors have meaningfully diversified study footprint away from China since 2022. Poland, India, the Czech Republic, Spain, and Brazil are now routine sites for Phase II and III work that a decade ago would have been concentrated in the US, Western Europe, and China. The CRA, who must monitor sites in person and remotely, has to live near where studies enroll.
Regulators legitimized remote and decentralized monitoring. The FDA's 2023 draft guidance on decentralized clinical trials and the EMA's recommendation paper on decentralized elements both formalized hybrid monitoring as acceptable when adequately controlled. CRAs can now legitimately be placed in a country adjacent to the site rather than always co-located.
ICH-GCP E6(R3) raised the bar on oversight, not co-location. The ICH-GCP E6(R3) guideline, adopted in early 2025, emphasizes risk-proportionate monitoring and sponsor oversight. Sponsors are accountable for quality regardless of where the CRA is employed, which makes the employment vehicle (contractor, EOR, entity) a compliance question, not just an HR one.
The combined effect: CRA hiring is now a global sourcing problem. Sponsors and CROs that solve it well hire from talent hubs that match their trial map, on locally compliant employment contracts, without paying nine months of entity-setup time per country.
Where CRAs actually live and what they cost
Loaded cost (gross salary plus statutory employer contributions) is the right way to compare. Statutory rates vary materially. Use country statistical agencies and OECD as the source of truth.
EU hubs: Poland, Portugal, Spain, Czechia
These four jurisdictions are the most common European CRA hires Borderless and other EORs see.
- Poland. Long-established CRO bench (Parexel, IQVIA, ICON, and Medpace all run substantial Polish operations). Polish employer social contributions run roughly 19.21% to 22.41% of gross salary on top of base, per ZUS contribution rates.
- Portugal. Lower salary point than Spain, English-fluent, English-language clinical training pipelines through Lisbon and Porto universities. Employer Social Security contribution sits at 23.75% of gross.
- Spain. Larger pool than Portugal; the Spanish Social Security employer rate totals roughly 30% to 32% of gross depending on contingencies. Common for HEOR-adjacent CRAs and senior monitors.
- Czechia. Mid-cost EU bench with strong Phase I to III experience. Czech employer social and health contributions total 33.8% of gross.
Loaded cost, as a working planning ratio: assume 1.20× to 1.35× gross salary for these four countries before benefits top-ups. The OECD Taxing Wages dataset is the cleanest cross-country comparison for confirming employer-side wedge.
APAC: India and Philippines
India remains the largest single CRA market outside the US. Major CROs disclose substantial India headcount in public filings; IQVIA's 2024 10-K lists India as one of its largest delivery footprints, and ICON plc's annual report similarly identifies India as a strategic delivery location. Indian statutory employer contributions (EPF + ESI + gratuity reserve) typically add 13% to 15% on top of base, per the EPFO contribution schedule.
The Philippines is a smaller but growing center, especially for English-language pharmacovigilance-adjacent CRA work. Philippine employer SSS, PhilHealth, and Pag-IBIG contributions add roughly 10% to 13% of gross.
A planning loaded-cost stack for an India-based CRA II in 2026, before discretionary benefits:
This is a planning range, not a quote. Country-specific finance review is required.
LATAM: Brazil and Mexico
Brazil is the largest LATAM clinical-trial market and the natural CRA hub for Portuguese-language sites. Brazilian employer contributions, including INSS, FGTS, and the so-called "Sistema S," cumulatively add 28% to 37% on top of gross depending on industry classification, before 13th-month and vacation accruals.
Mexico anchors Spanish-language CRA hiring across the region. IMSS and Infonavit employer contributions total roughly 25% to 30% of gross. The Mexican CRA bench is smaller than Brazil's but has grown notably as sponsors diversify LATAM site selection.
Hiring Clinical Research Associates by Country
Clinical Research Associate hiring patterns vary by country. The differences usually involve five operational areas: local CRA experience depth, labor-law structure, travel expectations, statutory employer costs, and sponsor oversight requirements.
The sections below outline how sponsors and CROs commonly approach international CRA hiring through an Employer of Record.
Poland
Typical CRA profile
Poland has one of the deepest CRA talent pools in Central and Eastern Europe. Many Polish CRAs come from large CRO environments with Phase II and III monitoring experience across oncology, CNS, and metabolic studies.
Local labor structure
EOR hiring is common for sponsors building small Polish monitoring teams before opening a permanent entity.
Travel considerations
Poland is frequently used as a regional monitoring hub for Central and Eastern Europe. Schengen mobility simplifies cross-border monitoring coverage.
Loaded cost tendencies
Employer social contributions usually add roughly 19% to 23% above gross salary before discretionary benefits.
Is EOR appropriate?
Yes. Poland is one of the most established EOR markets for CRA hiring.
Common compliance friction
Sponsors should review:
- working-time treatment for travel
- fixed-term employment limits
- local payroll reporting requirements
Portugal
Typical CRA profile
Portugal offers a strong English-speaking CRA bench, particularly for remote and hybrid monitoring roles.
Local labor structure
Sponsors commonly use EOR structures for early EU expansion and remote clinical operations coverage.
Travel considerations
Portugal-based CRAs frequently support broader EU monitoring programs.
Loaded cost tendencies
Employer Social Security contributions typically add roughly 23.75% above gross salary.
Is EOR appropriate?
Yes, especially for distributed EU monitoring models.
Common compliance friction
Sponsors should review:
- fixed-term contract limitations
- mandatory holiday entitlements
- travel reimbursement documentation
Spain
Typical CRA profile
Spain has a large CRA talent pool with strong oncology, rare disease, and HEOR-adjacent experience.
Local labor structure
EOR hiring is frequently used for Spanish CRA hires before long-term entity expansion.
Travel considerations
Spain is commonly used for Iberian and Southern European site coverage.
Loaded cost tendencies
Employer social contributions often add roughly 30% to 32% above gross salary.
Is EOR appropriate?
Yes. Spain is one of the more mature CRA hiring markets in Europe.
Common compliance friction
Sponsors should account for:
- labor-reform restrictions on temporary contracts
- working-time rules
- travel-time treatment
Czechia
Typical CRA profile
Czech CRAs are commonly sourced from established Phase I through III clinical operations environments.
Local labor structure
Sponsors often use EOR structures for smaller monitoring teams and startup clinical operations.
Travel considerations
Czechia is commonly used as a regional hub for nearby EU trial sites.
Loaded cost tendencies
Employer social and health contributions total roughly 33.8% above gross salary.
Is EOR appropriate?
Yes, particularly for small-to-mid-sized CRA teams.
Common compliance friction
Sponsors should review:
- overtime rules
- local payroll reporting
- reimbursement documentation
India
Typical CRA profile
India remains one of the largest global CRA hiring markets outside the United States. Indian CRAs commonly support large multi-regional monitoring programs.
Local labor structure
EOR hiring is widely used for Indian CRA teams supporting global studies.
Travel considerations
Domestic monitoring travel can be extensive due to geographic scale and site distribution.
Loaded cost tendencies
Employer statutory contributions commonly add roughly 13% to 15% above gross salary before discretionary benefits.
Is EOR appropriate?
Yes. India is one of the most common EOR markets for CRO and sponsor hiring.
Common compliance friction
Sponsors should account for:
- gratuity accrual
- EPF compliance
- regional travel policies
- overtime expectations
Philippines
Typical CRA profile
The Philippines is a growing English-language CRA and pharmacovigilance-support market.
Local labor structure
Sponsors often use EOR arrangements for regional APAC support functions.
Travel considerations
International travel requirements should be reviewed early for broader APAC monitoring programs.
Loaded cost tendencies
Employer contributions commonly add roughly 10% to 13% above gross salary.
Is EOR appropriate?
Yes, particularly for remote-support and hybrid-monitoring structures.
Common compliance friction
Sponsors should review:
- overtime compliance
- holiday-pay obligations
- local payroll administration rules
Brazil
Typical CRA profile
Brazil has the largest CRA talent market in LATAM, particularly for Portuguese-language monitoring coverage.
Local labor structure
EOR hiring is frequently used for LATAM expansion before entity setup.
Travel considerations
Domestic travel requirements can be significant due to geographic scale and site concentration.
Loaded cost tendencies
Employer contributions commonly add roughly 28% to 37% above gross salary before mandatory accruals.
Is EOR appropriate?
Yes. Brazil is one of the most common LATAM EOR markets.
Common compliance friction
Sponsors should review:
- 13th-month salary accruals
- FGTS obligations
- vacation accrual treatment
- travel reimbursement policies
Mexico
Typical CRA profile
Mexico supports growing Spanish-language CRA operations across LATAM studies.
Local labor structure
Sponsors commonly use EOR structures for regional monitoring teams.
Travel considerations
Mexico-based CRAs are frequently used for broader regional monitoring coverage.
Loaded cost tendencies
Employer contributions commonly add roughly 25% to 30% above gross salary.
Is EOR appropriate?
Yes, especially for regional LATAM hiring.
Common compliance friction
Sponsors should review:
- mandatory profit-sharing obligations
- overtime treatment
- payroll tax compliance
Germany
Typical CRA profile
German CRAs often have strong oncology, rare disease, and medical-device trial experience.
Local labor structure
Sponsors frequently use EOR structures before building larger German operations.
Travel considerations
Germany is commonly used as a DACH monitoring hub.
Loaded cost tendencies
Employer contributions are materially higher than many APAC markets and should be modeled carefully.
Is EOR appropriate?
Yes, especially for initial German expansion.
Common compliance friction
Sponsors should account for:
- working-time rules
- travel-time treatment
- works council considerations
- termination compliance
United Kingdom
Typical CRA profile
UK CRA teams commonly support both domestic and pan-European monitoring programs.
Local labor structure
EOR hiring is widely used by US sponsors and CROs building UK monitoring coverage.
Travel considerations
UK-based CRAs often support broader European monitoring structures.
Loaded cost tendencies
Employer National Insurance contributions and pension obligations should be modeled into loaded-cost calculations.
Is EOR appropriate?
Yes. The UK remains one of the more mature EOR markets for clinical operations hiring.
Common compliance friction
Sponsors should review:
- IR35 contractor rules
- working-time compliance
- pension auto-enrollment obligations
Contractor vs EOR vs local entity for CRA hiring
Three vehicles, three different risk profiles.
1099 / independent contractor. Same-day setup. Pay-per-invoice. The honest constraint: most CRAs do not meet the legal definition of an independent contractor. They follow a sponsor-defined monitoring plan, work fixed hours, use sponsor systems, and represent the sponsor at sites. The US Department of Labor's economic-realities test, as codified in the 2024 final rule at 29 CFR Part 795, treats that pattern as employment. Healthcare-staffing misclassification has been actively enforced; see the 2022 DOL consent judgment recovering $9.3 million for misclassified home health aides. Most non-US jurisdictions apply parallel tests. Contractor status for a full-time CRA is rarely defensible.
Employer of Record. A third party legally employs the CRA in their home country, on a locally compliant contract, while the sponsor or CRO directs day-to-day work. The time to first hire can be anywhere from days to two weeks. The CRA gets statutory benefits, the sponsor gets clean payroll and termination compliance, and there is no entity to wind down if the trial map changes.
Local entity. Best when headcount in a country crosses roughly 10 to 20 employees and the sponsor expects multi-year presence. Setup typically takes three to nine months and runs $15K to $50K+ before recurring legal, accounting, and payroll costs. For a single CRA in Czechia, this is overbuilt. For a 30-person Polish operations hub, it is right-sized.
A useful sequencing rule: start in a new country via EOR, migrate to a local entity once the team is stable above the cost crossover. Many CROs and sponsors run this exact path.
What to check on a CRA's credentialing and country-of-residence status
EOR removes the employment-law question. It does not remove sponsor diligence on the CRA themselves.
- GCP training currency. Confirm TransCelerate-recognized GCP training is current. Most sponsors require refresh every two to three years.
- Therapeutic-area experience documentation. CV evidence of monitoring visits per protocol type, plus references from prior sponsor or CRO relationships.
- Country of residence and right to work. The CRA's tax-residency country determines which entity employs them. A CRA "based in" Lisbon but tax-resident in Brazil is a different legal hire than one tax-resident in Portugal. Get this in writing before contracting.
- Site-monitoring travel reach. Confirm passport, Schengen residency or visa status, and any country-entry restrictions for the trial map.
- Conflicts and prior-employment non-competes. Especially relevant for ex-CRO hires moving to sponsors.
ICH-GCP E6(R3) keeps sponsor responsibility for monitoring quality with the sponsor regardless of who is the legal employer. The EOR does not absorb that responsibility.
The monitoring-visit travel and expense reality
A working CRA spends real time on the road even in a hybrid-monitoring world. Sponsors and CROs that under-budget travel pay for it later in attrition.
Plan for:
- 8 to 14 site visits per CRA per year for Phase II and III, lower for purely remote-monitored protocols.
- Per-visit travel envelope of $400 to $2,000 in EU intra-region, higher for cross-region.
- Reimbursement compliance under local rules. The EOR will pass through expenses, but the sponsor must define the policy. Some countries (Germany, France) treat per-diems and mileage on specific statutory schedules.
- Working-time and rest rules. EU Working Time Directive limits and national variants apply to travel time in some jurisdictions. Worth a country-by-country review before a heavy-monitoring protocol launches.
A travel and expense policy attached to the employment contract avoids most of the recurring friction.
30/60/90-day setup through an EOR
What a clean rollout looks like for a sponsor or CRO hiring its first international CRAs.
- Days 1 to 7. Provider verification (entities held in target countries, GCP-relevant data-handling, sanctions screening). MSA signed. Country and role list locked. Onboarding portal access.
- Days 7 to 21. First country live. Locally compliant employment contract issued in the CRA's language. Background and credential checks (GCP training, prior-employment, where-applicable license verification). Statutory and supplemental benefits enrolled. Trial-system access (CTMS, eTMF, EDC) provisioned by the sponsor.
- Days 21 to 45. First payroll cycle runs. HRIS sync confirmed (Workday, BambooHR, or similar). Expense and time-off processes verified against the monitoring-visit travel policy. Equity treatment confirmed if applicable.
- Days 45 to 90. Second and third countries onboarded on the same template. Quarterly compliance review scheduled. Country-specific anomalies reviewed (Brazilian 13th-month and FGTS, Polish PIT-2 elections, Indian gratuity accrual, Spanish fixed-term restrictions under the 2022 labor reform).
Sponsors who treat the first 90 days as a structured rollout, not a one-off hire, get materially better results from any EOR.
Honest limits: what an EOR does not solve for CRA hiring
The most useful thing this article can say is what EOR does not do.
- It does not transfer investigator responsibility. The principal investigator at each site, not the sponsor or the CRA, is accountable under FDA Form 1572 and the analogous EU CTR provisions. EOR is silent on this.
- It does not replace site contracts. Clinical trial agreements between sponsor and site, including budget, indemnification, and publication rights, sit outside any employment vehicle.
- It does not absorb sponsor pharmacovigilance obligations. Adverse-event reporting under ICH E2A and 21 CFR 312.32 stays with the sponsor.
- It does not substitute for sponsor monitoring oversight. ICH-GCP E6(R3) keeps quality accountability with the sponsor regardless of who employs the CRA.
- It does not grant clinical licensure where a CRA's role overlaps with regulated clinical activity (rare for monitoring, but worth checking in jurisdictions with restrictive scope rules).
EOR solves employment compliance. The clinical-quality system is still the sponsor's.
FAQs
Can I hire a clinical research associate in another country without opening an entity?
Yes. An Employer of Record legally employs the CRA in their home country on a locally compliant contract, while the sponsor or CRO directs the work. This is the standard route for the first several CRA hires per country.
Is it legal to engage a CRA as an independent contractor?
Rarely, for full-time CRAs. CRAs typically follow sponsor-defined monitoring plans, work fixed hours, and use sponsor systems. These patterns fail the DOL economic-realities test and parallel tests in most non-US jurisdictions. Misclassification exposes the sponsor to back-taxes, overtime, and benefits liability.
Where do most CRAs live in 2026?
Heavy concentrations in the US, UK, Poland, Spain, Portugal, Germany, Czechia, India, the Philippines, Brazil, and Mexico. The right map for any given sponsor follows its trial site footprint.
How long does it take to hire a CRA through an EOR?
Typically days to two weeks from signed MSA to local employment contract issued. Compare to three to nine months for entity setup.
Does an EOR replace ICH-GCP sponsor responsibilities?
No. ICH-GCP E6(R3) keeps sponsor responsibility for monitoring quality and oversight regardless of who is the legal employer. EOR is an employment vehicle, not a clinical-quality system.
What does a remote CRA cost loaded in Poland or Portugal?
Plan for 1.20× to 1.35× gross salary before discretionary benefits, driven by ZUS or Social Security employer contributions. Confirm with country-specific finance review.
What is the difference between an EOR and a CRO staffing vendor?
A CRO staffing vendor helps sponsors source and recruit Clinical Research Associates. An Employer of Record becomes the legal employer in the CRA’s country, handling payroll, employment contracts, statutory benefits, tax withholding, and labor-law compliance. Sponsors and CROs often use both models together: the staffing vendor identifies the CRA candidate, and the EOR employs them locally where the sponsor or CRO does not have an entity.
Further reading
- Why Medical Companies are Turning to Employer of Record services
- Hiring Medical Science Liaisons Internationally
- How Medical Device Companies are Staffing Rollouts
- EOR for Biotech Startups on Tight Runway
- Global Hiring for Digital-Health and Telemedicine Companies
- How Tech Companies Are Turning to Employer of Record Services
Borderless helps sponsors and CROs hire Clinical Research Associates internationally through owned-entity EOR infrastructure across 170+ countries. For country-specific onboarding, payroll, and employment guidance for clinical operations teams, speak with Borderless AI’s healthcare team.
